• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Cytomedix Inc.

Court approves Nuo Therapeutics bankruptcy plan

March 30, 2016 By Brad Perriello

Wound care company Nuo Therapeutics (OTC:NUOT) said yesterday that a federal court in Delaware approved a bankruptcy plan that would either see it continue as an independent company or become 95% owned by lender Deerfield Management. Gaithersburg, Md.-based Nuo filed for Chapter 11 bankruptcy protection in January, 2 years after raising $35 million from Deerfield. Formerly known as Cytomedix, […]

Filed Under: Legal News, Wound Care Tagged With: Bankruptcy, Cytomedix Inc., Deerfield Management, Nuo Therapeutics

Nuo Therapeutics files for bankruptcy

January 27, 2016 By Brad Perriello

Wound care company Nuo Therapeutics (OTC:NUOT) said yesterday that it’s declaring Chapter 11 bankruptcy a little more than 2 years after raising $35 million. Formerly known as Cytomedix, Nuo Therapeutics makes the Aurix hematogel, which is designed to stimulate the body’s native mechanisms to heal wounds. In April 2014, the company landed a $35 million investment from Deerfield […]

Filed Under: Wall Street Beat, Wound Care Tagged With: Bankruptcy, Cytomedix Inc., Deerfield Management, Nuo Therapeutics

DOD hands out $99.6 million in contracts to Hologic, GE, PositiveID | Medtech funding stories for the week of Apr. 7, 2014

April 11, 2014 By MassDevice Leave a Comment

Hologic, GE, PositiveID land near $100M in Defense contracts

April 7, 2014 by Arezu Sarvestani

Hologic, GE, PositiveID lands nearly $100M in Pentagon contracts

Filed Under: Funding Roundup, News Well Tagged With: Cytomedix Inc., Deerfield Management, defensedepartment, Delphi Ventures, Domain Associates, Foresite Capital, GE Healthcare, Hologic, PositiveID Corp., reflexion-health, Sequent Medical, Sofinnova Partners, US Venture Partners, Venrock, Versant Ventures

Stryker hits a new lifetime high in shares | Medtech Wall Street news for the week of Apr. 7, 2014

April 10, 2014 By MassDevice Leave a Comment

Stryker shares hit new lifetime high | MassDevice.com On Call

April 7, 2014 by Arezu Sarvestani

MassDevice.com On Call

Filed Under: News Well, Wall Street Beat Tagged With: Cytomedix Inc., Deerfield Management, Delcath Systems Inc., NASDAQ, Stryker, TriVascular, Vital Therapies

Deerfield raises $1.6B healthcare fund

April 8, 2014 By Brad Perriello

Deerfield raises $1.6B healthcare fund

Deerfield Management Co. said it raised a fund aimed at healthcare investments that’s worth $1.6 billion.

Deerfield Private Design Fund III is "designed to provide flexible private financing to healthcare companies," according to a press release.

Filed Under: Funding Roundup, News Well, Wall Street Beat, Wound Care Tagged With: Cytomedix Inc., Deerfield Management

Stealthy Auris Surgical Robotics raises more than $34 million in an equity round | Medtech funding stories for the week of Mar. 31, 2014

April 4, 2014 By MassDevice Leave a Comment

Stealthy Auris Surgical Robotics raises $34M for eye-surgery device

April 1, 2014 by Brad Perriello

Stealthy Auris Surgical Robotics raises $34M for eye-surgery device

Filed Under: Funding Roundup, News Well Tagged With: Auris Surgical Robotics, Axonics Modulation Technologies, Cytomedix Inc., Deerfield Management, Halt Medical, Highland Capital Partners, Lux Capital, Mithril Capital Management, NaviMed, Transcend Medical Inc., Vessix Vascular Inc.

Cytomedix lands $35M for wound care products

April 2, 2014 By Arezu Sarvestani

Cytomedix lands $35M for wound care products

Wound care therapies maker Cytomedix(OTC:CMXI) landed a $35 million investment commitment from Deerfield Management Co., to be handed down in 2 tranches.

Filed Under: Funding Roundup, Medicare, News Well, Wound Care Tagged With: Cytomedix Inc., Deerfield Management, Wound Therapy

Cytomedix raises $3M for regenerative therapies

December 13, 2013 By Chris Walker Leave a Comment

Cytomedix raises $3M

Gaithersburg, Md.-based medical device company Cytomedix (OTC:CMXI) raised $3 million from 10 investors, SEC documents show.

Filed Under: Funding Roundup, News Well, Regenerative Medicine Tagged With: Cytomedix Inc.

Cytomedix touts reimbursement win

March 20, 2013 By Sony Salzman Leave a Comment

Cytomedix logo

Cytomedix (OTC:CMXI) touted a reimbursement win from the Centers for Medicare & Medicaid Services for plasma systems including its AutoloGel product.

The coverage decision includes Cytomedix’s platelet-rich plasma system for patients with chronic ulcers and wounds, under the Coverage with Evidence Development program, a CMS guidance policy that gathers data and public comments to include in coverage decisions.

Filed Under: Blood Management, News Well Tagged With: Coverage, Cytomedix Inc.

Cytomedix touts $28M 2013 funding plan, drops 20% on The Street

February 20, 2013 By MassDevice staff Leave a Comment

Cytomedix logo

Regenerative therapies maker Cytomedix (OTC:CMXI) plans to raise up to $27.5 million through a "comprehensive 2013 financing plan" in order to maintain the momentum that led to record sales in the last quarter.

Filed Under: Blood Management, Funding Roundup, News Well, Wall Street Beat Tagged With: Cytomedix Inc.

Cytomedix touts CE Mark for Angel plasma system

December 10, 2012 By MassDevice staff Leave a Comment

cytomedix logo

Cytomedix (OTC:CMXI) received the CE Mark approval in the European Union for its Angel concentrated platelet rich plasma system.

Filed Under: News Well Tagged With: Cytomedix Inc.

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS